SHARON R HYMES

TitleProfessor
InstitutionMD Anderson
DepartmentDermatology
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ronen S, Keiser E, Collins KM, Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Hymes S, Medeiros LJ, Torres-Cabala CA. Langerhans cell sarcoma involving skin and showing epidermotropism: A comprehensive review. J Cutan Pathol. 2021 Apr; 48(4):547-557. PMID: 32644218.
      Citations:    Fields:    Translation:Humans
    2. Ciurea SO, Hansrivijit P, Ciurea AM, Hymes S, Chen J, Rondon G, Hosing C, Popat U, Champlin RE. Curative potential of hematopoietic stem cell transplantation for advanced psoriasis. Am J Hematol. 2019 06; 94(6):E176-E180. PMID: 30900768.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    3. Arudra K, Patel R, Tetzlaff MT, Hymes S, Subbiah V, Meric-Bernstam F, Torres-Cabala C, Aung PP, Nagarajan P, Diab A, Prieto VG, Nelson K, Curry JL. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. J Cutan Pathol. 2018 Oct; 45(10):786-790. PMID: 30021048.
      Citations: 4     Fields:    Translation:Humans
    4. Bush AE, Hymes SR, Silapunt S. Lichenoid Dermatitis From Interferon alpha-2a in a Patient With Metastatic Renal Cell Carcinoma and Seronegative HCV. J Drugs Dermatol. 2017 Jul 01; 16(7):714-716. PMID: 28697228.
      Citations: 1     Fields:    Translation:HumansCells
    5. Curry JL, Tetzlaff MT, Nagarajan P, Drucker C, Diab A, Hymes SR, Duvic M, Hwu WJ, Wargo JA, Torres-Cabala CA, Rapini RP, Prieto VG. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. J Cutan Pathol. 2017 Feb; 44(2):158-176. PMID: 27859479.
      Citations: 35     Fields:    Translation:Humans
    6. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31641040.
      Citations:    Fields:    Translation:HumansAnimals
    7. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29872368.
      Citations: 3     
    8. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27098388.
      Citations: 2     Fields:    Translation:HumansCells
    9. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 26997441.
      Citations: 6     Fields:    Translation:HumansCells
    10. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 7979448.
      Citations:    Fields:    Translation:Humans
    11. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22421124.
      Citations: 6     Fields:    Translation:Humans
    12. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18441766.
      Citations: 5     Fields:    Translation:Humans
    13. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19951629.
      Citations: 1     Fields:    Translation:Humans
    14. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22193645.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    15. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21892091.
      Citations: 10     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    16. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22077555.
      Citations:    Fields:    Translation:Humans
    17. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3980801.
      Citations: 9     Fields:    Translation:HumansCells
    18. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16384753.
      Citations: 121     Fields:    Translation:Humans
    19. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18651821.
      Citations: 3     Fields:    Translation:Humans
    20. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3889081.
      Citations: 3     Fields:    Translation:HumansCells
    21. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24993601.
      Citations: 4     Fields:    Translation:Humans
    22. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 1733660.
      Citations:    Fields:    Translation:Humans
    23. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 2007680.
      Citations: 6     Fields:    Translation:Humans
    24. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 2370118.
      Citations: 1     Fields:    Translation:Humans
    25. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3955897.
      Citations:    Fields:    Translation:HumansCells
    26. Wuu A, Bangert SD, Weber DM, Hymes SR. Primary cutaneous plasmacytoma. Cutis. 2014 Jun; 93(6):E19-21. PMID: 24999652.
      Citations: 1     Fields:    Translation:Humans
    27. Nadeem S, Hymes S, Kebriaei P, Abruzzo L, Curry JL, Duvic M. Alopecia areata after HLA-identical BMT from an affected, sibling donor. Bone Marrow Transplant. 2014 Apr; 49(4):592-4. PMID: 24442249.
      Citations: 1     Fields:    Translation:Humans
    28. Wright NA, Torres-Cabala CA, Curry JL, Cutlan JE, Hymes SR. Post-varicella-zoster virus granulomatous dermatitis: a report of 2 cases. Cutis. 2014 Jan; 93(1):50-4. PMID: 24505586.
      Citations: 1     Fields:    Translation:HumansCells
    29. Falchook GS, Rady P, Hymes S, Nguyen HP, Tyring SK, Prieto VG, Hong DS, Kurzrock R. Merkel cell polyomavirus and HPV-17 associated with cutaneous squamous cell carcinoma arising in a patient with melanoma treated with the BRAF inhibitor dabrafenib. JAMA Dermatol. 2013 Mar; 149(3):322-6. PMID: 23552670.
      Citations: 6     Fields:    Translation:HumansCells
    30. Alexander LJ, Paravar T, Duvic M, Prieto V, Hymes SR. Annular plaques: An unusual manifestation of graft-versus-host disease. Dermatol Online J. 2012 Jun 15; 18(6):4. PMID: 22747928.
      Citations: 1     Fields:    Translation:Humans
    31. Sweeney SA, Kumar VA, Tayar J, Weber DM, Safdar A, Alonso C, Hymes S. Case 181: synovitis acne pustulosis hyperostosis osteitis (SAPHO) syndrome. Radiology. 2012 May; 263(2):613-7. PMID: 22517965.
      Citations: 4     Fields:    Translation:Humans
    32. Hymes SR, Alousi AM, Cowen EW. Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease. J Am Acad Dermatol. 2012 Apr; 66(4):515.e1-18; quiz 533-4. PMID: 22421123.
      Citations: 18     Fields:    Translation:HumansCells
    33. Alousi A, Ghosh S, Rice D, Moran C, Manning JT, Iliescu C, Hymes S, Kim S, Bashoura L, Kornblau S, Dickey BF. Pleuropericarditis, obliterative bronchiolitis and lymphocytic interstitial pneumonitis after allogeneic haematopoietic stem cell transplantation. BMJ Case Rep. 2011 Feb 23; 2011. PMID: 22707568.
      Citations: 1     Fields:    Translation:HumansCells
    34. Diamantis ML, Richmond HM, Rady PL, Tyring SK, Cutlan JE, Torres-Cabala C, Hymes SR. Detection of human papillomavirus in multiple eccrine poromas in a patient with chronic graft-vs-host disease and immunosuppression. Arch Dermatol. 2011 Jan; 147(1):120-2. PMID: 21242407.
      Citations: 4     Fields:    Translation:Humans
    35. Geddes ER, Polder K, Cutlan JE, Torres-Cabala CA, Hymes SR. Ulcerated plaque under a ruby ring in an immunosuppressed patient. Dermatol Online J. 2010 Aug 15; 16(8):4. PMID: 20804681.
      Citations: 1     Fields:    Translation:HumansAnimals
    36. Rashid R, Hymes S. Folliculitis, follicular mucinosis, and papular mucinosis as a presentation of chronic myelomonocytic leukemia. Dermatol Online J. 2009 May 15; 15(5):16. PMID: 19624994.
      Citations: 2     Fields:    Translation:Humans
    37. Braiteh F, Hymes SR, Giralt SA, Jones R. Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma. J Clin Oncol. 2008 Sep 20; 26(27):4511-3. PMID: 18802165.
      Citations: 3     Fields:    Translation:Humans
    38. Chrastil B, Fornage B, Nash J, Hymes SR. A black plaque on the toe of a white male. Int J Dermatol. 2008 Sep; 47(9):977-8. PMID: 18937671.
      Citations:    Fields:    Translation:HumansAnimals
    39. Kunishige JH, Hymes SR, Madkan V, Wyatt AJ, Uptmore D, Lazar AJ, Giralt S, Rady P, Tyring S. Epidermodysplasia verruciformis in the setting of graft-versus-host disease. J Am Acad Dermatol. 2007 Nov; 57(5 Suppl):S78-80. PMID: 17938030.
      Citations: 3     Fields:    Translation:Humans
    40. Mays SR, Kunishige JH, Truong E, Kontoyiannis DP, Hymes SR. Approach to the morbilliform eruption in the hematopoietic transplant patient. Semin Cutan Med Surg. 2007 Sep; 26(3):155-62. PMID: 18070682.
      Citations: 2     Fields:    Translation:Humans
    41. Hymes SR, Turner ML, Champlin RE, Couriel DR. Cutaneous manifestations of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2006 Nov; 12(11):1101-13. PMID: 17085303.
      Citations: 14     Fields:    Translation:Humans
    42. Yee KW, Hymes SR, Heller L, Prieto VG, Welch MA, Giles FJ. Cutaneous leukocytoclastic vasculitis in a patient with myelodysplastic syndrome after therapy with the rapamycin analogue everolimus: case report and review of the literature. Leuk Lymphoma. 2006 May; 47(5):926-9. PMID: 16753882.
      Citations:    Fields:    Translation:Humans
    43. Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, Shaughnessy P, Hymes S, Kim S, Wayne AS, Chien JW, Neumann J, Mitchell S, Syrjala K, Moravec CK, Abramovitz L, Liebermann J, Berger A, Gerber L, Schubert M, Filipovich AH, Weisdorf D, Schubert MM, Shulman H, Schultz K, Mittelman B, Pavletic S, Vogelsang GB, Martin PJ, Lee SJ, Flowers ME. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant. 2006 Apr; 12(4):375-96. PMID: 16545722.
      Citations: 85     Fields:    Translation:HumansPHPublic Health
    44. Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, Moresi JM, Greenson J, Janin A, Martin PJ, McDonald G, Flowers ME, Turner M, Atkinson J, Lefkowitch J, Washington MK, Prieto VG, Kim SK, Argenyi Z, Diwan AH, Rashid A, Hiatt K, Couriel D, Schultz K, Hymes S, Vogelsang GB. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant. 2006 Jan; 12(1):31-47. PMID: 16399567.
      Citations: 109     Fields:    Translation:Humans
    45. Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B, Smith V, Khouri I, Giralt S, de Lima M, Hsu Y, Ghosh S, Neumann J, Andersson B, Qazilbash M, Hymes S, Kim S, Champlin R, Donato M. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood. 2006 Apr 15; 107(8):3074-80. PMID: 16368882.
      Citations: 55     Fields:    Translation:Humans
    46. Jih MH, Friedman PM, Kimyai-Asadi A, Friedman ES, Hymes SR, Goldberg LH. Lupus miliaris disseminatus faciei: treatment with the 1450-nm diode laser. Arch Dermatol. 2005 Feb; 141(2):143-5. PMID: 15724009.
      Citations: 3     Fields:    Translation:Humans
    47. Boccia R, Anné PR, Bourhis J, Brizel D, Daly C, Holloway N, Hymes S, Koukourakis M, Kozloff M, Turner M, Wasserman T. Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Int J Radiat Oncol Biol Phys. 2004 Sep 01; 60(1):302-9. PMID: 15337569.
      Citations: 1     Fields:    Translation:Humans
    48. Thurber M, Feasel A, Stroehlein J, Hymes SR. Pustular psoriasis induced by infliximab. J Drugs Dermatol. 2004 Jul-Aug; 3(4):439-40. PMID: 15303790.
      Citations: 10     Fields:    Translation:Humans
    49. Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, Trancik RJ, Bandstra BA, Compton LD. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol. 1996 Jul; 35(1):74-8. PMID: 8682968.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    50. Vine JE, Hymes SR, Warner NB, Cohen PR. Pustular psoriasis induced by hydroxychloroquine: a case report and review of the literature. J Dermatol. 1996 May; 23(5):357-61. PMID: 8675829.
      Citations: 5     Fields:    Translation:Humans
    51. Meyerson MA, Cohen PR, Hymes SR. Lingual hyperpigmentation associated with minocycline therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Feb; 79(2):180-4. PMID: 7614181.
      Citations: 8     Fields:    Translation:Humans
    52. Cohen PR, Hymes SR. Linear and dermatomal cutaneous graft-versus-host disease. South Med J. 1994 Jul; 87(7):758-61. PMID: 8023213.
      Citations: 2     Fields:    Translation:Humans
    53. Dhingra K, Duvic M, Hymes S, McLaughlin P, Rothberg J, Gutterman JU. A phase-I clinical study of low-dose oral interferon-alpha. J Immunother Emphasis Tumor Immunol. 1993 Jul; 14(1):51-5. PMID: 8399070.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    54. Hymes SR, Jordon RE. Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy. Arch Dermatol. 1992 Nov; 128(11):1462-4. PMID: 1444499.
      Citations: 1     Fields:    Translation:Humans
    55. Schauder CS, Hymes SR, Rapini RP, Zipf TF. Vesicular graft-versus-host disease. Int J Dermatol. 1992 Jul; 31(7):509-10. PMID: 1500247.
      Citations: 1     Fields:    Translation:Humans
    56. Norman J, Cruse W, Ruas E, Beatty E, Hymes S, Espinosa C, Clark R, Reintgen D. The expanding role of lymphoscintigraphy in the management of cutaneous melanoma. First Place Winner: Conrad Jobst award. Am Surg. 1989 Dec; 55(12):689-94. PMID: 2596765.
      Citations:    Fields:    Translation:Humans
    57. Hymes SR, Jordon RE. Chronic cutaneous lupus erythematosus. Med Clin North Am. 1989 Sep; 73(5):1055-71. PMID: 2671532.
      Citations:    Fields:    Translation:Humans
    58. Hymes SR, Russell TJ, Jordon RE. The anti-Ro antibody system. Int J Dermatol. 1986 Jan-Feb; 25(1):1-7. PMID: 3512458.
      Citations:    Fields:    Translation:HumansAnimals
    59. Hymes SR, Farmer ER, Burns WH, Morison WL, Tutschka PJ, Walters LL, Santos GW. Bullous sclerodermalike changes in chronic graft-vs-host disease. Arch Dermatol. 1985 Sep; 121(9):1189-92. PMID: 3899019.
      Citations:    Fields:    Translation:Humans
    60. Hymes SR, Farmer ER, Lewis PG, Tutschka PJ, Santos GW. Cutaneous graft-versus-host reaction: prognostic features seen by light microscopy. J Am Acad Dermatol. 1985 Mar; 12(3):468-74. PMID: 3989008.
      Citations: 4     Fields:    Translation:Humans
    61. Cutaneous manifestations of chronic graft versus host disease. 169-181.
    62. Pleuropericarditis, obliterative bronchiolitis and lymphocytic interstitial pneumonitis after allogeneic haematopoietic stem cell transplantation. BMJ Case Reports.
    63. Bullous Sclerodermalike Changes in Chronic Graft-vs-Host Disease. Archives of Dermatology. 121:1189-1192.
    64. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. Journal of Cutaneous Pathology. 44:158-176.
    65. Case 181. Radiology. 262:361-363.
    66. Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors. Archives of Dermatological Research. 1-9.
    67. Recurrent Facial Plaques Following Full-Thickness Grafting. Archives of Dermatology. 130:1435-1436.
    HYMES's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (312)
    Explore
    _
    Co-Authors (55)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _